hfx ltd Revenue and Competitors

UK

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • hfx ltd's estimated annual revenue is currently $2.5M per year.(i)
  • hfx ltd's estimated revenue per employee is $101,500

Employee Data

  • hfx ltd has 25 Employees.(i)

hfx ltd's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
COOReveal Email/Phone
3
Head Quality AssuranceReveal Email/Phone
4
Director Customer ServicesReveal Email/Phone
5
Group Cloud and Infrastructure ManagerReveal Email/Phone
6
Customer Account ManagerReveal Email/Phone
7
Service Delivery and Supply Chain ManagerReveal Email/Phone
8
Group Operations ManagerReveal Email/Phone
9
Implementation and Support ConsultantReveal Email/Phone
10
National Sales ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$77.3M4356%$106MN/A
#2
$34.9M2247%$224MN/A
#3
$58.3M328-25%$73.1MN/A
#4
$0.5M7N/AN/AN/A
#5
$167.1M806-4%$17MN/A
#6
$78.8M435N/AN/AN/A
#7
$12.9M89N/AN/AN/A
#8
$3.6M31N/AN/AN/A
#9
$65.4M355-14%$103.3MN/A
#10
$1.2M14N/AN/AN/A
#11
$0.4M6N/AN/AN/A
#12
$31.7M199N/AN/AN/A
#13
$5.2M45N/AN/AN/A
#14
$0.4M6N/AN/AN/A
#15
$35.9M230-3%$65.2MN/A
#16
$1.5M17N/AN/AN/A
#17
$5.1M442%N/AN/A
#18
$40.5M26916%$80.2MN/A
#19
$2.7M27N/AN/AN/A
#20
$6.7M51N/AN/AN/A
Add Company

What Is hfx ltd?

keywords:N/A

N/A

Total Funding

25

Number of Employees

$2.5M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

hfx ltd News

2022-03-30 - Rhoifolin from Plumula Nelumbinis exhibits anti-cancer effects ...

Therefore, the need for new drugs with limited side effects is ... to a Q Exactive HFX Orbitrap instrument (Thermo Fisher Scientific,...

2022-03-22 - Saluda's Evoke SCS Set To Join Competitive US Spine-Stim ...

Now it plans to expand its proprietary HFX high-frequency ... The company plans to implement a controlled, limited release of Evoke SCS in...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.5M25N/AN/A
#2
$2.5M25N/AN/A
#3
$2.5M25N/AN/A
#4
$2.5M25N/AN/A
#5
$2.5M25N/AN/A